Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by wagyusteakon Sep 03, 2020 8:24pm
79 Views
Post# 31508526

RE:RE:RE:RE:Welcome to squeeze-out day !!!

RE:RE:RE:RE:Welcome to squeeze-out day !!!
porksniffer wrote:
wagyusteak wrote:
porksniffer wrote:
drippingsnot wrote: All outstanding shares (remaining 2%) to be aquired today at the going rate.

"...the procedure for the squeeze out of the remaining BDRs of the Company, as provided in Section 2.6 of the Tender Offer Notice (“
Squeeze-Out”), shall take place at B3 S.A. – Brasil, Bolsa, Balco (the “B3”) on September 3, 2020.  The Offeror will pay the amount of BRL10.40 per BDR, which will no longer be traded at B3 from August 28, 2020 (inclusive) onwards."

Cheers !



Stop the insanity. 'Squeeze out' is fukkking meaningless. lol You keep posting this same thing over and over. I think the market is aware we will own 100% of this turd. Fast approaching a 50% loss in value off the high. This is fast becoming embarrasing. How does management go to work every day? Tomorrow we go into the $5's. Not a single share has been purchased, last buyback they were buying well into the $7's, which tells you which direction management thinks the share price is headed.


Paladin dropped from $10 to $3 multiple times you cuck. Can't handle the volatility, gtfo. Lol. Your daddy Meir is not here to rescue you.
 



Who you think you're fooling, cuck. You weren't the only one there. 

It went to $10 in 2000 during the dotcom/telecom/biopharma bubble when the 'parent' was shoveling drugs to sell and then dropped to $3.00 in the 2002 post 9/11 bear market. Nearly every small cap showed the same price action. You aren't fooling anyone you dumb cuck. I can sense your frustration lmao. How much are you losing here, cuck? lmao. Keep your hate on for Meir. Your CEO's BEST investment was in MEIR AND his company. lmao


LOL. so are we not in the fking bubble right now you dumb cuck?  
<< Previous
Bullboard Posts
Next >>